Susquehanna International Group’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.04M | Sell |
544,700
-28,600
| -5% | -$301K | ﹤0.01% | 4635 |
|
|
2025
Q4 | $6.74M | Buy |
573,300
+239,100
| +72% | +$2.58M | ﹤0.01% | 3582 |
|
|
2025
Q3 | $2.58M | Buy |
334,200
+26,200
| +9% | +$184K | ﹤0.01% | 5263 |
|
|
2025
Q2 | $2.25M | Buy |
308,000
+85,300
| +38% | +$688K | ﹤0.01% | 5545 |
|
|
2025
Q1 | $2.11M | Sell |
222,700
-161,600
| -42% | -$2.02M | ﹤0.01% | 5406 |
|
|
2024
Q4 | $6.33M | Sell |
384,300
-90,100
| -19% | -$1.4M | ﹤0.01% | 3252 |
|
|
2024
Q3 | $7M | Buy |
474,400
+45,600
| +11% | +$714K | ﹤0.01% | 3090 |
|
|
2024
Q2 | $5.95M | Sell |
428,800
-158,500
| -27% | -$2.25M | ﹤0.01% | 3171 |
|
|
2024
Q1 | $9.23M | Buy |
587,300
+63,800
| +12% | +$985K | ﹤0.01% | 2717 |
|
|
2023
Q4 | $8.47M | Buy |
523,500
+390,800
| +294% | +$6.39M | ﹤0.01% | 2873 |
|
|
2023
Q3 | $1.63M | Sell |
132,700
-300
| -0.2% | -$4.46K | ﹤0.01% | 5558 |
|
|
2023
Q2 | $2.14M | Sell |
133,000
-46,900
| -26% | -$773K | ﹤0.01% | 5013 |
|
|
2023
Q1 | $3.13M | Buy |
179,900
+45,700
| +34% | +$651K | ﹤0.01% | 4247 |
|
|
2022
Q4 | $1.24M | Sell |
134,200
-47,100
| -26% | -$439K | ﹤0.01% | 5725 |
|
|
2022
Q3 | $1.56M | Buy |
181,300
+29,400
| +19% | +$292K | ﹤0.01% | 5496 |
|
|
2022
Q2 | $1.24M | Buy |
151,900
+123,900
| +443% | +$1.18M | ﹤0.01% | 6003 |
|
|
2022
Q1 | $340K | Sell |
28,000
-1,600
| -5% | -$33.7K | ﹤0.01% | 9970 |
|
|
2021
Q4 | $1.01M | Sell |
29,600
-70,600
| -70% | -$2.76M | ﹤0.01% | 7267 |
|
|
2021
Q3 | $4.83M | Buy |
100,200
+16,200
| +19% | +$750K | ﹤0.01% | 4015 |
|
|
2021
Q2 | $3.79M | Sell |
84,000
-9,600
| -10% | -$425K | ﹤0.01% | 4539 |
|
|
2021
Q1 | $4.51M | Buy |
93,600
+38,500
| +70% | +$2M | ﹤0.01% | 4107 |
|
|
2020
Q4 | $2.97M | Buy |
55,100
+9,400
| +21% | +$425K | ﹤0.01% | 4330 |
|
|
2020
Q3 | $1.69M | Sell |
45,700
-37,900
| -45% | -$1.41M | ﹤0.01% | 4948 |
|
|
2020
Q2 | $2.59M | Sell |
83,600
-43,900
| -34% | -$1.22M | ﹤0.01% | 4044 |
|
|
2020
Q1 | $3.52M | Buy |
+127,500
| New | +$3.82M | ﹤0.01% | 3047 |
|
|
2019
Q3 | – | Sell |
-48,500
| Closed | -$1.06M | – | 10609 |
|
|
2019
Q2 | $1.06M | Sell |
48,500
-87,800
| -64% | -$1.93M | ﹤0.01% | 5503 |
|
|
2019
Q1 | $2.79M | Buy |
136,300
+74,700
| +121% | +$1.3M | ﹤0.01% | 3237 |
|
|
2018
Q4 | $777K | Buy |
61,600
+28,400
| +86% | +$423K | ﹤0.01% | 5170 |
|
|
2018
Q3 | $510K | Buy |
+33,200
| New | +$459K | ﹤0.01% | 6482 |
|
|
2018
Q2 | – | Sell |
-25,400
| Closed | -$207K | – | 10120 |
|
|
2018
Q1 | $207K | Sell |
25,400
-4,400
| -15% | -$35.6K | ﹤0.01% | 8270 |
|
|
2017
Q4 | $264K | Sell |
29,800
-29,500
| -50% | -$272K | ﹤0.01% | 7806 |
|
|
2017
Q3 | $660K | Buy |
+59,300
| New | +$577K | ﹤0.01% | 6034 |
|
|
2017
Q2 | – | Sell |
-34,400
| Closed | -$271K | – | 9598 |
|
|
2017
Q1 | $271K | Sell |
34,400
-4,400
| -11% | -$35.8K | ﹤0.01% | 7504 |
|
|
2016
Q4 | $333K | Buy |
38,800
+28,400
| +273% | +$243K | ﹤0.01% | 7781 |
|
|
2016
Q3 | $85K | Buy |
+10,400
| New | +$87.3K | ﹤0.01% | 8003 |
|
|
2016
Q2 | – | Sell |
-51,800
| Closed | -$349K | – | 9063 |
|
|
2016
Q1 | $349K | Buy |
51,800
+3,000
| +6% | +$19.7K | ﹤0.01% | 7019 |
|
|
2015
Q4 | $384K | Buy |
+48,800
| New | +$357K | ﹤0.01% | 7256 |
|
|
2015
Q3 | – | Sell |
-22,000
| Closed | -$119K | – | 9973 |
|
|
2015
Q2 | $119K | Buy |
22,000
+11,700
| +114% | +$60.3K | ﹤0.01% | 9606 |
|
|
2015
Q1 | $48K | Buy |
+10,300
| New | +$44.8K | ﹤0.01% | 9159 |
|
|
2014
Q4 | – | Sell |
-24,100
| Closed | -$126K | – | 9941 |
|
|
2014
Q3 | $126K | Sell |
24,100
-3,400
| -12% | -$17.5K | ﹤0.01% | 8988 |
|
|
2014
Q2 | $91K | Buy |
27,500
+10,100
| +58% | +$33.6K | ﹤0.01% | 9448 |
|
|
2014
Q1 | $60K | Buy |
+17,400
| New | +$65.2K | ﹤0.01% | 8685 |
|
Other funds holding NEO
FLAM
GF
VPM
VCM
B
Susquehanna International Group's NEO Position: Q1 2026 in Review
Susquehanna International Group increased its NeoGenomics (NEO) stake by 230% in Q1 2026, buying an estimated $348K and bringing the position to 47,452 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #10518.
Susquehanna International Group first reported a position in NEO in Q4 2013 and has held it in 37 quarters since. The position peaked at $5.23M in Q4 2020. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.
- Susquehanna International Group held 47,452 shares of NeoGenomics worth $352K as of Q1 2026.
- Susquehanna International Group bought 33,082 NeoGenomics shares in Q1 2026, an estimated $348K.
- NeoGenomics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10518 holding.
- Susquehanna International Group first reported a position in NeoGenomics in Q4 2013 and has held it in 37 quarters since.
- Susquehanna International Group's NeoGenomics position peaked at $5.23M in Q4 2020.
- 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.